In addition, Sox2 has been shown to have a key role in GBM progression and recurrence, because its silencing in GBM CSCs leads to a drastic reduction in their capacity for invasion, proliferation, and tumorigenicity [51]. Here, SOX2 is linked to glioblastoma.